BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

University of Washington Spinout Cardiac Insight Wins FDA OK for Heartbeat Monitor


6/7/2013 7:35:53 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cardiac Insight Receives 510(k) Clearance for Wearable Monitor for Outpatient ECG Monitoring

Bellevue,WA (PRWEB) June 05, 2013- Cardiac Insight, Inc., a company focused on the diagnosis and treatment of cardiac arrhythmias, today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for its Stealth™ body-worn ECG monitor.

The Stealth™ is a lightweight, adhesive, low power, disposable monitor designed to be worn by patients for an entire day. The device enables diagnostic-quality ECG recordings and is form fitting to the patient’s anatomy.

The monitor provides both doctors and patients with the potential for an improved experience, ease of use and speedier results. The Stealth™ device cleared by the FDA will be the platform for the company’s future devices.

“Early diagnosis and treatment of conditions such as atrial fibrillation will reduce the costs associated with acute care of unexpected strokes and cardiovascular disease,” said Brad Harlow, CEO and Co-Founder of Cardiac Insight. He went on to say, “We will continue to work on the development of a highly accurate atrial fibrillation monitor to address the “silent” a-fib market, those patients with undiagnosed, difficult to detect atrial fibrillation, followed by other arrhythmias.”

About Cardiac Insight:

Founded in 2008 and with general operations underway in June 2010 with financing, the company is focused on the development of products to enable the early detection of heart disease and related conditions. Core technology utilizes proprietary technology licensed from the University of Washington.

The company intends to further develop and commercialize enhanced versions of the monitor specifically for the detection of atrial fibrillation and other conditions.

Company Contact:

Brad Harlow

brad(at)cardiacinsight(dot)us

+1 425-818-2175



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES